Biotech Stocks to Buy: NPS Pharmaceuticals (NPSP)
NPS Pharmacuticals (NPSP) currently has five drugs for things like osteoporosis, hyperparathyroidism, pain management and short bowel syndrome. They focus their research efforts right now on things like gastrointestinal, psychiatric, neurological and bone and mineral disorders. The company had triple digit gains in sales and earnings in the most recent quarter and the strong fundamentals were noticed by Portfolio Grader.
The stock was upgraded to an A back in December and remains a strong buy at the current price.
Louis Navellier is the editor of Blue Chip Growth.